Stock CGTX COGNITION THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Cognition Therapeutics, Inc.

Equities

CGTX

US19243B1026

Market Closed - Nasdaq
Other stock markets
 04:30:00 2024-04-30 pm EDT 		5-day change 1st Jan Change
1.91 USD -1.04% Intraday chart for Cognition Therapeutics, Inc. -4.50% +3.24%
Apr. 29 Cognition Therapeutics, Inc. Completes Enrollment in Phase 2 SHIMmer Study of CT1812 in Mild-to-Moderate Dementia with Lewy Bodies CI
Apr. 12 Transcript : Cognition Therapeutics, Inc. - Special Call

Chart calendar Cognition Therapeutics, Inc.

0471f27c2e81eef653a8.k93h4TmJxEDnlxmovBE7grrcAtQ4smcWHL0zgmHbKvI.p4TMzEHDiQPT8Gv39GV-4824VPlJ8B9iZPVh6TnvYITUn6KxbuCJddHIQA~b317ced1d53a05daab90bcfa84ec122a

Upcoming events on Cognition Therapeutics, Inc.

2024-05-07 Q1 2024 Earnings Release (Projected)
2024-08-05 Q2 2024 Earnings Release (Projected)
2024-11-12 Q3 2024 Earnings Release (Projected)
2025-03-25 Q4 2024 Earnings Release (Projected)

Past events on Cognition Therapeutics, Inc.

2024-04-12 08:00 am Investor Meeting - Key Opinion Leader
2024-04-11 08:00 am Needham Healthcare Conference
2024-03-26 08:00 am Q4 2023 Earnings Call
2024-03-26 07:00 am Q4 2023 Earnings Release
2024-03-07 Alzheimer and Parkinson Diseases International Conference
2024-03-05 Alzheimer and Parkinson Diseases International Conference
2024-03-04 Alzheimer and Parkinson Diseases International Conference
2024-03-04 02:50 pm TD Cowen Health Care Conference
2023-11-14 Society For Neuroscience Meeting - Session PSTR527
2023-11-13 Society For Neuroscience Meeting - Session PSTR402
2023-11-13 Society For Neuroscience Meeting - Session PSTR402
2023-11-02 07:30 am Q3 2023 Earnings Release
2023-09-26 09:20 am Cantor Global Healthcare Conference
2023-09-19 04:10 pm Longwood Healthcare Leaders Fall Conference
2023-09-13 04:00 pm H.C. Wainwright Global Investment Conference
2023-08-08 08:00 am Q2 2023 Earnings Call
2023-08-08 07:00 am Q2 2023 Earnings Release
2023-06-28 08:00 am CT1812 Phase 2 Study Results Call
2023-06-23 10:30 am Cantor Fitzgerald Virtual Brain Week Conference - Panel
2023-06-12 03:30 pm Mass General Brigham World Medical Innovation Forum - Panel

Annual results

Fiscal PeriodDecember 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		0,00


0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBITDA
Released
Forecast
Spread 		0,00


0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBIT
Million USD		Released
Forecast
Spread 		0,00


-28,6
-24,0
-19.32%		-43,6
-47,5
8.38%		-50,7
-51,7
1.8%
-64,8

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		0,00


-11,7
-5,20
-125.31%		-21,4
-22,2
3.42%		-25,8
-27,8
7.3%
-39,2

Net income
Million USD		Released
Forecast
Spread 		-12,1


-16,2
-9,50
-71.03%		-21,4
-22,2
3.42%		-25,8
-27,8
7.3%
-39,2

EPS
USD		Released
Forecast
Spread 		-7,35


-3,13
-0,49
-538.78%		-0,91
-0,92
1.09%		-0,86
-0,93
7.28%
-0,98

Announcement Date07/05/2130/03/2223/03/2326/03/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00


0,00


0,00


0,00

EBIT
Million USD		Released
Forecast
Spread 		-11,8
-7,22
-63.49%		-9,41
-10,5
10.59%		-12,2
-9,63
-26.84%		-12,6
-12,9
2.2%		-9,30
-13,2
29.33%		-8,97
-10,5
14.24%		-11,8
-11,4
-4.01%		-14,7
-14,2
-3.76%		-15,2
-16,1
5.77%
-15,7


-16,3


-16,9


-17,6

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-7,34
-0,80
-817.38%		-3,71
-6,05
38.61%		-5,88
-7,41
20.68%		-6,63
-8,76
24.39%		-5,18
-5,94
12.81%		-6,17
-5,65
-9.28%		-4,73
-6,22
24%		-6,75
-8,26
18.26%		-8,14
-10,2
19.96%
-8,52


-8,13


-9,32


-10,4

Net income
Million USD		Released
Forecast
Spread 		-7,55
-0,80
-843.13%		-3,84
-6,45
40.48%		-5,75
-7,41
22.37%		-6,63
-8,76
24.39%		-5,18
-5,94
12.81%		-6,17
-5,65
-9.28%		-4,73
-6,22
24%		-6,75
-8,26
18.26%		-8,14
-10,2
19.96%
-8,52


-8,13


-9,32


-10,4

EPS
USD		Released
Forecast
Spread 		-0,40
-0,04
-900%		-0,17
-0,29
40.7%		-0,25
-0,32
21.88%		-0,29
-0,38
24.35%		-0,20
-0,23
11.11%		-0,21
-0,18
-18.87%		-0,16
-0,19
15.79%		-0,22
-0,24
7.37%		-0,27
-0,31
11.96%
-0,25


-0,22


-0,20


-0,19

Announcement Date30/03/2211/05/2209/08/2214/11/2223/03/2304/05/2308/08/2302/11/2326/03/24----

Upcoming sector events for Cognition Therapeutics, Inc.

Today 07:00 am NEUROCRINE BIOSCIENCES, INC.: Q1 2024 Earnings Release
Today 04:05 pm SAREPTA THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-05-01 ZENTALIS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected)
2024-05-01 DENALI THERAPEUTICS INC.: Q1 2024 Earnings Release (Projected)
2024-05-01 GERON CORPORATION: Q1 2024 Earnings Release
2024-05-01 KURA ONCOLOGY, INC.: Q1 2024 Earnings Release
2024-05-01 KEROS THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
2024-05-01 ALECTOR, INC.: Q1 2024 Earnings Release (Projected)
2024-05-01 ULTRAGENYX PHARMACEUTICAL INC.: Q1 2024 Earnings Release
2024-05-01 TRAVERE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
More events

Past sector events for Cognition Therapeutics, Inc.

Today SUMMIT THERAPEUTICS INC.: Q1 2024 Earnings Release
Today MACROGENICS, INC.: Q1 2024 Earnings Release (Projected)
Today REGENXBIO INC.: Q1 2024 Earnings Release (Projected)
Today DECIPHERA PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected)
2024-04-30 04:05 pm EXELIXIS, INC.: Q1 2024 Earnings Release
2024-04-29 DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
2024-04-29 ARVINAS, INC.: Q1 2024 Earnings Release (Projected)
2024-04-29 MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.: Q1 2024 Earnings Release
2024-04-29 07:00 am WUXI APPTEC CO., LTD.: Q1 2024 Earnings Release
2024-04-28 INVENTISBIO CO., LIMITED: Q1 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. CGTX Stock
  4. Calendar Cognition Therapeutics, Inc.